The Cigna Group (CI) FY2024 Annual Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2024-01-01 to 2024-12-31

Swipe to see the full flow
The Cigna Group cash flow reconciliation, Jan 1, 2024 through Dec 31, 2024One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $3,778,000,000.00Pharmacy and other service costs payable → Operating adjustments reconciliation: $8,757,000,000.00Depreciation and amortization → Operating adjustments reconciliation: $2,775,000,000.00Investment losses, net → Operating adjustments reconciliation: $2,737,000,000.00Accounts payable and Accrued expenses and other liabilities → Operating adjustments reconciliation: $1,138,000,000.00Other, net → Operating adjustments reconciliation: $774,000,000.00Operating adjustments reconciliation → Net cash from operating activities: $6,585,000,000.00Operating adjustments reconciliation → Accounts receivable, net: $7,369,000,000.00Operating adjustments reconciliation → Inventories: $1,032,000,000.00Operating adjustments reconciliation → Insurance liabilities: $591,000,000.00Operating adjustments reconciliation → Reinsurance recoverable and Other assets: $485,000,000.00Operating adjustments reconciliation → Deferred income tax benefit: $95,000,000.00Operating adjustments reconciliation → Net (gain) loss on sale of businesses: $24,000,000.00Debt securities and equity securities → investing reconciliation: $856,000,000.00Debt securities and equity securities → investing reconciliation: $839,000,000.00Other sales, maturities and repayments (primarily short-term and other long-term investments) → investing reconciliation: $752,000,000.00Divestitures, net of cash sold → investing reconciliation: $521,000,000.00Commercial mortgage loans → investing reconciliation: $188,000,000.00Other, net → investing reconciliation: $58,000,000.00investing reconciliation → Property and equipment purchases, net: $1,406,000,000.00investing reconciliation → Debt securities and equity securities: $1,386,000,000.00investing reconciliation → Other (primarily short-term and other long-term investments): $1,309,000,000.00investing reconciliation → Renewable energy tax credit equity investments: $1,030,000,000.00investing reconciliation → Acquisitions, net of cash acquired: $131,000,000.00investing reconciliation → Commercial mortgage loans: $54,000,000.00Net cash used in financing activities → financing reconciliation: $7,647,000,000.00Net proceeds on issuance of long-term debt → financing reconciliation: $4,462,000,000.00Issuance of common stock → financing reconciliation: $305,000,000.00Deposits and interest credited to contractholder deposit funds → financing reconciliation: $166,000,000.00financing reconciliation → Repurchase of common stock: $7,034,000,000.00financing reconciliation → Repayment of long-term debt: $3,000,000,000.00financing reconciliation → Common stock dividend paid: $1,567,000,000.00financing reconciliation → Net change in short-term debt: $402,000,000.00financing reconciliation → Other, net: $349,000,000.00financing reconciliation → Withdrawals and benefit payments from contractholder deposit funds: $228,000,000.00Net cash used in investing activities → investing reconciliation: $2,102,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations → Cash sources and uses: $8,337,000,000.00Net cash from operating activities → Cash sources and uses: $10,363,000,000.00Cash sources and uses → Exchange-rate effect: $20,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $8,931,000,000.00Cash sources and uses → Net cash used in investing activities: $2,102,000,000.00Cash sources and uses → Net cash used in financing activities: $7,647,000,000.00Other, net: $774,000,000.00Other working capital, net+$774.00 MAccounts payable and Accrued expenses and other liabilities: $1,138,000,000.00Accounts payable and Accrued expenses and otherliabilities+$1.14 BDeferred income tax benefit: -$95,000,000.00Deferred tax balances−$95.00 MDepreciation and amortization: $2,775,000,000.00Depreciation & amortization+$2.78 BInventories: -$1,032,000,000.00Inventories−$1.03 BNet income: $3,778,000,000.00Net income+$3.78 BInsurance liabilities: -$591,000,000.00Insurance liabilities−$591.00 MAccounts receivable, net: -$7,369,000,000.00Accounts & other receivables−$7.37 BInvestment losses, net: $2,737,000,000.00Investment losses, net+$2.74 BPharmacy and other service costs payable: $8,757,000,000.00Pharmacy and other service costs payable+$8.76 BReinsurance recoverable and Other assets: -$485,000,000.00Reinsurance recoverables−$485.00 MNet (gain) loss on sale of businesses: -$24,000,000.00Business sale gain & loss−$24.00 MNet cash from operating activities: $10,363,000,000.00Operating cash+$10.36 BOperating adjustments reconciliation: $16,181,000,000.00Net change in short-term debt: -$402,000,000.00Net change in short-term debt−$402.00 MNet proceeds on issuance of long-term debt: $4,462,000,000.00Long-term debt issued+$4.46 BRepayment of long-term debt: -$3,000,000,000.00Long-term debt repaid−$3.00 BOther, net: -$349,000,000.00Other financing, net−$349.00 MWithdrawals and benefit payments from contractholder deposit funds: -$228,000,000.00Policyholder withdrawals−$228.00 MRepurchase of common stock: -$7,034,000,000.00Common stock repurchases−$7.03 BCommon stock dividend paid: -$1,567,000,000.00Common dividends paid−$1.57 BIssuance of common stock: $305,000,000.00Common stock issued+$305.00 MDeposits and interest credited to contractholder deposit funds: $166,000,000.00Policyholder deposits+$166.00 MNet cash used in financing activities: -$7,647,000,000.00. Cash required to fund net payments.Financing cash−$7.65 Bfinancing reconciliation: $12,580,000,000.00Debt securities and equity securities: $856,000,000.00Debt securities and equity securities+$856.00 MAcquisitions, net of cash acquired: -$131,000,000.00Acquisitions, net of cash−$131.00 MOther sales, maturities and repayments (primarily short-term and other long-term investments): $752,000,000.00Other investment proceeds+$752.00 MOther (primarily short-term and other long-term investments): -$1,309,000,000.00Other investment purchases−$1.31 BOther, net: $58,000,000.00Other investing, net+$58.00 MCommercial mortgage loans: -$54,000,000.00Mortgage note purchases−$54.00 MDebt securities and equity securities: $839,000,000.00Debt securities and equity securities+$839.00 MDivestitures, net of cash sold: $521,000,000.00Business sales, net of cash+$521.00 MDebt securities and equity securities: -$1,386,000,000.00Debt securities and equity securities−$1.39 BProperty and equipment purchases, net: -$1,406,000,000.00Property and equipment purchases, net−$1.41 BCommercial mortgage loans: $188,000,000.00Loan collections+$188.00 MRenewable energy tax credit equity investments: -$1,030,000,000.00Equity-method investments made−$1.03 BNet cash used in investing activities: -$2,102,000,000.00. Cash required to fund net payments.Investing cash−$2.10 Binvesting reconciliation: $5,316,000,000.00Cash sources and uses: $18,700,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $8,337,000,000.00Beginning cash$8.34 BEnding cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $8,931,000,000.00Ending cash$8.93 BExchange-rate effect: -$20,000,000.00FX effect−$20.00 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flowNot availableCash flow / Net income2.74×Operating cash flow ÷ net incomeNet cash change+$594.00 MEnding cash − beginning cash
Chart details

The Cigna Group cash flow reconciliation, Jan 1, 2024 through Dec 31, 2024

Cash flows for Jan 1, 2024 through Dec 31, 2024. Cash basis: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Beginning cash: Dec 31, 2023. Ending cash: Dec 31, 2024. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2023
8,337,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Operating activities
10,363,000,000 US dollars. Net cash provided.
Other, net
774,000,000 US dollars
Accounts payable and Accrued expenses and other liabilities
1,138,000,000 US dollars
Deferred income tax benefit
negative 95,000,000 US dollars
Depreciation and amortization
2,775,000,000 US dollars
Inventories
negative 1,032,000,000 US dollars
Net income
3,778,000,000 US dollars
Insurance liabilities
negative 591,000,000 US dollars
Accounts receivable, net
negative 7,369,000,000 US dollars
Investment losses, net
2,737,000,000 US dollars
Pharmacy and other service costs payable
8,757,000,000 US dollars
Reinsurance recoverable and Other assets
negative 485,000,000 US dollars
Net (gain) loss on sale of businesses
negative 24,000,000 US dollars
Investing activities
negative 2,102,000,000 US dollars. Net cash used.
Debt securities and equity securities
856,000,000 US dollars
Acquisitions, net of cash acquired
negative 131,000,000 US dollars
Other sales, maturities and repayments (primarily short-term and other long-term investments)
752,000,000 US dollars
Other (primarily short-term and other long-term investments)
negative 1,309,000,000 US dollars
Other, net
58,000,000 US dollars
Commercial mortgage loans
negative 54,000,000 US dollars
Debt securities and equity securities
839,000,000 US dollars
Divestitures, net of cash sold
521,000,000 US dollars
Debt securities and equity securities
negative 1,386,000,000 US dollars
Property and equipment purchases, net
negative 1,406,000,000 US dollars
Commercial mortgage loans
188,000,000 US dollars
Renewable energy tax credit equity investments
negative 1,030,000,000 US dollars
Financing activities
negative 7,647,000,000 US dollars. Net cash used.
Net change in short-term debt
negative 402,000,000 US dollars
Net proceeds on issuance of long-term debt
4,462,000,000 US dollars
Repayment of long-term debt
negative 3,000,000,000 US dollars
Other, net
negative 349,000,000 US dollars
Withdrawals and benefit payments from contractholder deposit funds
negative 228,000,000 US dollars
Repurchase of common stock
negative 7,034,000,000 US dollars
Common stock dividend paid
negative 1,567,000,000 US dollars
Issuance of common stock
305,000,000 US dollars
Deposits and interest credited to contractholder deposit funds
166,000,000 US dollars
Operating adjustment reconciliation
16,181,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
12,580,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
5,316,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
negative 20,000,000 US dollars
Ending cash on Dec 31, 2024
8,931,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Cash sources and uses
18,700,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
594,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
2.74×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $6.59B after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
The Cigna Group (CI) FY2024 Annual Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!